Intelligence Platform

Patents

Browse 401 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8394377

Methods for treating cancer using combination therapy

The Regents of the University of Colorado · Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8361471

Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD

The Regents of the University of Colorado · Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8337830

Yeast-based vaccines as immunotherapy

The Regents of the University of Colorado · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8329753

Combination of compounds, or a bifunctional compound, that provides fatty acid metabolism

The Regents of the University of Colorado · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8318490

Prelamin A pre peptide as a universal stem cell differentiation signal

The Regents of the University of Colorado, a Body Corporate · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8293240

Method of treating drug-resistant cancer

The Regents of the University of Colorado · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8293275

Spray freeze dry of compositions for pulmonary administration

The Regents of the University of Colorado · Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8282963

Methods for extracting platelets and compositions obtained therefrom

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8252737

Antimicrobial peptides and methods of use

The Regents of the University of Colorado · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8222392

Kit for detection of telomerase reverse transcriptase nucleic acids

The Regents of the University of Colorado · Granted Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8221763

Yeast-antigen compositions and methods of using the same

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8168415

Axl fusion proteins as Axl tyrosine kinase inhibitors

The Regents of the University of Colorado · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8163509

Biological markers predictive of anti-cancer response to insulin-like growth factor-1 rece

The Regents of the University of Colorado, a Body Corporate · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8153136

Yeast-based vaccines as immunotherapy

The Regents of the University of Colorado · Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8138312

Compositions for regulation of tumor necrosis factor-alpha

The Regents of the University of Colorado, a Body Corporate · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8137672

Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD

The Regents of the University of Colorado · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8093286

Methods for treatment with bucindolol based on genetic targeting

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8080578

Methods for treatment with bucindolol based on genetic targeting

The Regents of the University of Colorado, a Body Corporate · Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8076304

Methods and compositions for the diagnosis and treatment of cyclin A-1 associated conditio

The Regents of the University of Colorado · Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8071645

Systems and methods for treating human inflammatory and proliferative diseases and wounds,

The Regents of the University of Colorado · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8062643

Use of neurotoxin therapy for treatment of urologic and related disorders

The Regents of the University of Colorado · Granted Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8057807

Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

The Regents of the University of Colorado, a Body Corporate · Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039001

Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus in

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8017321

Gefitinib sensitivity-related gene expression and products and methods related thereto

The Regents of the University of Colorado, a Body Corporate · Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted